Hevasaf Hevasaf
12 May, 2026
9 mins read
48
In recent years, China has gradually become an important medical destination for international patients. Particularly in fields such as cancer treatment, CAR-T cell therapy, precision medicine, minimally invasive interventions, and comprehensive management of complex diseases, an increasing number of overseas patients are traveling to China in search of new treatment opportunities.
As China’s healthcare system continues to advance, many major hospitals have established international medical centers and continuously improved foreign-language services, international insurance support, and cross-border patient coordination processes. Compared with some countries, certain treatment programs in China offer greater advantages in appointment efficiency, clinical resources, and overall medical costs.
Over the past decade, China’s oncology healthcare system has developed rapidly. More and more large hospitals have established integrated medical systems covering diagnosis, treatment, and rehabilitation, while accumulating extensive clinical experience in the treatment of complex cancers.
Compared with the long waiting times in some countries, certain Chinese hospitals are more attractive to international patients in terms of appointment efficiency, coordinated multidisciplinary treatment, and overall treatment costs.
At the same time, an increasing number of hospitals have established international patient departments, providing English-language services, medical record translation, and cross-border medical support for overseas patients.
For international patients, the main advantages of China’s healthcare system include:
● Extensive clinical experience with large cancer case volumes
● Rapid development of precision medicine and cell therapy
● Increasingly mature MDT (Multidisciplinary Team) consultation systems
● Continuous improvement of international medical services and English support
Among the many oncology institutions in Guangzhou, RoyalLee Cancer Hospital Guangzhou has become one of the international cancer hospitals attracting growing attention from overseas patients in recent years.
Located in Guangzhou Knowledge City, the hospital is an international tertiary cancer specialty hospital and also a National Drug Clinical Trial Institution. The hospital has obtained JCI international accreditation and cooperates with multiple international commercial insurance providers.
The hospital has established a comprehensive cancer treatment system covering:
● Surgical oncology
● Radiotherapy
● Chemotherapy
● Minimally invasive interventional therapy
● Cancer rehabilitation
For many international patients, one of the hospital’s major strengths lies in its international service model and MDT multidisciplinary consultation system.
In recent years, more patients have shown interest in minimally invasive therapies that offer less trauma and faster recovery. The hospital currently provides several advanced treatment technologies, including:
● Y-90 therapy
● NanoKnife treatment
● Argon-helium cryoablation
● Radioactive seed implantation therapy
These technologies are gaining increasing attention among patients with advanced cancers, recurrent tumors, or inoperable conditions.
At the same time, the hospital places strong emphasis on the overall medical experience of international patients, offering services such as remote consultation, international insurance support, translation assistance, and cross-border medical coordination to help overseas patients complete their treatment journey in China more smoothly.

In addition to RoyalLee Cancer Hospital Guangzhou, Guangzhou is home to several other medical institutions popular among international patients.
This hospital has long treated international patients from Southeast Asia, the Middle East, and Africa, and has gained international recognition in minimally invasive oncology treatment, cryoablation, and comprehensive cancer management.
One of China’s most influential oncology institutions, with strong academic and clinical expertise in lung cancer, nasopharyngeal carcinoma, liver cancer, and precision radiotherapy.
Known for proton therapy and comprehensive international cancer treatment services, the hospital also collaborates with international cancer centers.
For overseas patients, choosing a hospital should involve more than simply considering reputation. More importantly, the hospital should match the patient’s disease type and treatment needs.
International patients are generally advised to focus on the following factors:
● Whether the hospital has an international medical department
● Whether it has experience serving international patients
● Whether it has strengths in the relevant specialty area
● Whether it supports remote consultations and long-term follow-up care
Different hospitals have different strengths. Some focus more on complex surgery and research capabilities, while others place greater emphasis on international patient experience and integrated management. Therefore, the hospital best suited to the patient is often more important than rankings alone.
Cross-border healthcare involves much more than simply making an appointment. It also includes medical record organization, hospital selection, specialist matching, medical translation, and ongoing treatment coordination.
DengYueMed is committed to helping international patients better understand China’s healthcare system and connect with leading Chinese medical resources, including RoyalLee Cancer Hospital Guangzhou.
As China’s innovative healthcare system continues to evolve, more international patients are expected to access advanced Chinese treatment technologies and innovative medical solutions through professional cross-border medical platforms.
Written By:
Now choose your stay according to your preference. From finding a place for your dream destination or a mere weekend getaway to business accommodations or brief stay, we have got you covered. Explore hotels as per your mood.